We next examined the effect of GSK923295 treatment on apoptosis induction and found that GSK923295 treatment induced apoptosis as demonstrated by increased numbers of annexin V-positive ovarian cancer cells as compared to control-treated cells (Fig. 6F). This evidence concerns the gene ANXA5 and ovarian carcinoma.